Agennix AG (GAGXF) Schedules Fiscal Year 2012 Reporting Date and Conference Call on March 28
2/19/2013 9:08:24 AM
More...
|
Agennix AG (GAGXF) Axes 55 Percent of Jobs as Part of Restructuring
8/24/2012 7:24:46 AM
More...
|
Agennix AG Reports Results of FORTIS-M Phase III Trial With Talactoferrin Alfa in Non-Small Cell Lung Cancer
8/7/2012 9:47:53 AM
More...
|
Agennix AG Reports Financial Results for Second Quarter and First Half of 2012
7/31/2012 9:16:30 AM
More...
|
Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments
7/30/2012 9:14:57 AM
More...
|
Agennix AG Schedules Conference Call on July 31 to Discuss Second Quarter 2012 Financial Results
7/25/2012 9:10:17 AM
More...
|
Agennix AG Reports Financial Results for First Quarter of 2012
5/9/2012 11:36:58 AM
More...
|
Agennix AG to Present at BioEquity Europe 2012 on May 15
5/4/2012 9:30:27 AM
More...
|
Agennix AG Schedules Conference Call on May 9 to Discuss First Quarter 2012 Financial Results
5/2/2012 8:22:35 AM
More...
|
Lonza Inc. and Agennix AG Sign Development and Manufacturing Deal for Production of Talactoferrin
4/12/2012 9:23:17 AM
More...
|
|